A review of multiple studies concluded that individuals taking berberine reported a significant reduction in body weight and BMI
and at regular intervals
This activity is supported by Sanofi
Some compounding pharmacies have pivoted to emphasizing the "clinically meaningful difference" angle, arguing that the addition of levocarnitine makes their product sufficiently different from commercial Mounjaro/Zepbound to justify continued compounding
GLP-1 inhibitor drugs, originally developed for managing type 2 diabetes, mimic hormones that regulate blood sugar levels, which can help decrease appetite and lower calorie intake
Built from first-hand experience with obesity by real GLP-1 patients, Shotsy offers multiple medication support, advanced dose-coded charts, maintenance mode, countdown widgets, and PDF exports